Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2015 Apr 23;75(5):1075–1087. doi: 10.1007/s00280-015-2737-4

Table 5.

Clinical trial pharmacokinetic results of IP paclitaxel instillation therapy

Study Year Paclitaxel delivery method Dose Cmax_IP
(μmol/L)a
T max_IP
(hours)
Cmax_IP/
Cmax_plasmaa
AUCIP/
AUCplasmaa
Markman [33] 1992 Instillation IP chemotherapy 25–175 mg/m2/3–4 weeks 175b 0.5–1 ~1000 996d
Francis [31] 1995 Instillation IP chemotherapy 30–75 mg/m2/week 50–1273c 0.5–2
Hofstra [34] 2002 Instillation IP chemotherapy 75 mg/m2 D1 + 8/4 week 1350d
Mohamed [35] 2003 Instillation IP chemotherapy 20 mg/m2/day for 5 days ~45 0.25 ~800
deBree [12] 2008 HIPEC 175 mg/m2 for 2 h 118 0.08 1178 1462 for 2 h (366
 total for 5 days period)
Nanotax® 2014 Instillation IP chemotherapy 50–275 mg/m2/4 weeks 1–61c 56 1168
a

Mean values

b

Mean value for 50–175 mg/m2 range

c

Range, not mean value

d

For the duration of IP instillation chemotherapy